Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancreatic Cancer.
Miller PN, Romero-Hernandez F, Calthorpe L, Wang JJ, Kim SS, Corvera CU, Hirose K, Kirkwood KS, Hirose R, Maker AV, Alseidi AA, Adam MA, Kim GE, Tempero MA, Ko AH, Nakakura EK.
Miller PN, et al. Among authors: kim ge.
Ann Surg Oncol. 2024 Jun 15. doi: 10.1245/s10434-024-15579-0. Online ahead of print.
Ann Surg Oncol. 2024.
PMID: 38879670